SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001038133-21-000054
Filing Date
2021-11-04
Accepted
2021-11-04 12:11:47
Documents
91
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q hska-20210930.htm   iXBRL 10-Q 2243526
2 EX-31.1 heska-09302021xex31x1.htm EX-31.1 11038
3 EX-31.2 heska-09302021xexx31x2.htm EX-31.2 10976
4 EX-32.1 heska-09302021xex32x1.htm EX-32.1 9580
10 LOGO hska-20210930_g1.jpg GRAPHIC 53004
  Complete submission text file 0001038133-21-000054.txt   10147963

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hska-20210930.xsd EX-101.SCH 57921
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hska-20210930_cal.xml EX-101.CAL 113189
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hska-20210930_def.xml EX-101.DEF 333506
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hska-20210930_lab.xml EX-101.LAB 744150
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hska-20210930_pre.xml EX-101.PRE 501259
11 EXTRACTED XBRL INSTANCE DOCUMENT hska-20210930_htm.xml XML 1957930
Mailing Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538
Business Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538 9704937272
HESKA CORP (Filer) CIK: 0001038133 (see all company filings)

IRS No.: 770192527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22427 | Film No.: 211378981
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences